Related Experiment Video
Updated: Aug 21, 2026
Live Imaging and Characterization of Microglia Dynamics and Interactions with Synapses in Diseased Murine Retina
Published on: January 16, 2026
Microglia-targeted pharmacotherapy in retinal neurodegenerative diseases
1University Eye Hospital Muenster, Department of Experimental Ophthalmology, Domagkstrasse 15, 48149 Muenster, Germany.
Abstract:
Microglial cells, members of the monocytic lineage, represent the resident immunocompetent cells of the central nervous system including the retina with its peculiarities like a double blood retinal barrier. Microglial cells invade the retina in response to naturally occurring neuronal death during embryonic development and remodelling. Resident microglial cells are extremely sensitive to changes in their microenvironment arising from either traumatic or chronic neurodegeneration, inproper wiring, hereditary diseases or infection and become rapidly activated. In their activated state, the cells undergo drastic morphological changes, upregulate a variety of receptors and secrete soluble factors, which contribute to recognition and phagocytotic cleareance of dying or malfunctioning neurons. In this review, we aim to summarise the current knowledge of microglial involvement in experimentally induced or naturally occurring retinal neurodegenerations with emphasising on mechanisms of microglia activation. Expanding on the mechanisms, we shall discuss on approaches to pharmacologically interfere with the microglial activation and neurophagy. The protagonistic role of these cells in the outcome of certain diseases may help designing microglial targeted treatments with potential benefit for neuronal survival and regeneration in clinically relevant conditions.
Insights
Microglial cells in the retina are key players in clearing dying neurons during neurodegeneration. Understanding their activation mechanisms can lead to new treatments for retinal diseases.
Area of Science:
- Neuroscience
- Immunology
- Ophthalmology
Background:
- Microglial cells are the primary immune cells of the central nervous system, including the retina.
- They are highly sensitive to changes in their microenvironment and become activated during neurodegenerative conditions.
- Activated microglia undergo morphological changes and phagocytose dying neurons.
Purpose of the Study:
- To review microglial cell involvement in retinal neurodegeneration.
- To emphasize the mechanisms of microglia activation in the retina.
- To discuss pharmacological strategies targeting microglial activation and neurophagy.
Main Methods:
- Literature review of microglial cell function in retinal neurodegeneration.
- Analysis of mechanisms underlying microglial activation.
- Exploration of therapeutic interventions targeting microglia.
Main Results:
- Microglial cells play a crucial role in clearing neuronal debris during retinal neurodegeneration.
- Specific mechanisms of microglial activation in response to retinal injury are detailed.
- Pharmacological approaches to modulate microglial activity show therapeutic potential.
Conclusions:
- Microglial cells are central to the progression and resolution of retinal neurodegenerative diseases.
- Targeting microglial activation pathways offers a promising strategy for neuroprotection and regeneration.
- Developing microglial-targeted therapies could significantly benefit patients with retinal conditions.
More Related Videos
12:48In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Published on: May 11, 2015
08:34Assessing Microglial Phagocytosis of Myelin Debris in vitro Under Repeated Magnetic Stimulation
Published on: June 17, 2025
